COS-LEP Phase 4

The next stage of the COS development process will obtain a broad consensus on the proposed set of core outcomes identified in Phase 1-3.

Delphi surveys targeted at stakeholders through the use an evolving questionnaire and multiple rounds of consensus surveys will be used.

Key stakeholder groups will include patients (those who experienced leptospirosis disease), infectious diseases healthcare professionals, non-infectious diseases healthcare professionals, allied global health researchers, and policymakers.

By the end of Phase 4, a narrowed list of outcomes will be produced which will have been assesed and voted on by stakeholders globally. This condensed list will be more appropriate to bring to a final consensus meeting.